Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment
Glyukokortikoidindutsirovannyy osteoporoz (GIO) - odno iz naibolee tyazhelykh oslozhneniy dlitel'noy (bolee 3 mes) sistemnoy terapii glyukokortikoidami (SGK). On razvivaetsya u bol'nykh lyubogo vozrasta i pola i yavlyaetsya naibolee chastoy sistemnoy formoy vtorichnogo osteoporoza (OP). By...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2008-03-01
|
| Series: | Современная ревматология |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/140 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849690474116284416 |
|---|---|
| author | I A Baranova I A Baranova |
| author_facet | I A Baranova I A Baranova |
| author_sort | I A Baranova |
| collection | DOAJ |
| description | Glyukokortikoidindutsirovannyy osteoporoz (GIO) - odno iz naibolee tyazhelykh oslozhneniy dlitel'noy (bolee 3 mes) sistemnoy terapii glyukokortikoidami (SGK). On razvivaetsya u bol'nykh lyubogo vozrasta i pola i yavlyaetsya naibolee chastoy sistemnoy formoy vtorichnogo osteoporoza (OP). Bystraya poterya kostnoy massy proiskhodit uzhe v pervye mesyatsy lecheniya SGK. Perelomy ot minimal'noy travmy voznikayut pri bolee vysokikh pokazatelyakh mineral'noy plotnosti kosti, chem u bol'nykh pervichnym OP. Dazhe ispol'zovanie malykh doz SGK privodit k povysheniyu riska perelomov, s uvelicheniem sutochnoy dozy risk perelomov vozrastaet. U patsientov, primenyayushchikh vysokie dozy ingalyatsionnykh GK (IGK), uvelichenie riska OP i perelomov v bol'shey stepeni obuslovleno tyazhest'yu respiratornogo zabolevaniya, chem terapiey IGK. Predstavleny sovremennye printsipy profilaktiki i lecheniya GIO. |
| format | Article |
| id | doaj-art-1098a4fbc3ac409a9fbe74d7f4879335 |
| institution | DOAJ |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2008-03-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-1098a4fbc3ac409a9fbe74d7f48793352025-08-20T03:21:18ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2008-03-0121313910.14412/1996-7012-2008-4551445Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatmentI A BaranovaI A BaranovaGlyukokortikoidindutsirovannyy osteoporoz (GIO) - odno iz naibolee tyazhelykh oslozhneniy dlitel'noy (bolee 3 mes) sistemnoy terapii glyukokortikoidami (SGK). On razvivaetsya u bol'nykh lyubogo vozrasta i pola i yavlyaetsya naibolee chastoy sistemnoy formoy vtorichnogo osteoporoza (OP). Bystraya poterya kostnoy massy proiskhodit uzhe v pervye mesyatsy lecheniya SGK. Perelomy ot minimal'noy travmy voznikayut pri bolee vysokikh pokazatelyakh mineral'noy plotnosti kosti, chem u bol'nykh pervichnym OP. Dazhe ispol'zovanie malykh doz SGK privodit k povysheniyu riska perelomov, s uvelicheniem sutochnoy dozy risk perelomov vozrastaet. U patsientov, primenyayushchikh vysokie dozy ingalyatsionnykh GK (IGK), uvelichenie riska OP i perelomov v bol'shey stepeni obuslovleno tyazhest'yu respiratornogo zabolevaniya, chem terapiey IGK. Predstavleny sovremennye printsipy profilaktiki i lecheniya GIO.https://mrj.ima-press.net/mrj/article/view/140 |
| spellingShingle | I A Baranova I A Baranova Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment Современная ревматология |
| title | Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment |
| title_full | Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment |
| title_fullStr | Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment |
| title_full_unstemmed | Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment |
| title_short | Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment |
| title_sort | glucocorticosteroid induced osteoporosis pathogenesis prevention treatment |
| url | https://mrj.ima-press.net/mrj/article/view/140 |
| work_keys_str_mv | AT iabaranova glucocorticosteroidinducedosteoporosispathogenesispreventiontreatment AT iabaranova glucocorticosteroidinducedosteoporosispathogenesispreventiontreatment |